Central Trust Company’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-52
| Closed | -$9K | – | 1319 |
|
|
2021
Q2 | $9K | Hold |
52
| – | – | ﹤0.01% | 1040 |
|
|
2021
Q1 | $8K | Hold |
52
| – | – | ﹤0.01% | 957 |
|
|
2020
Q4 | $7K | Hold |
52
| – | – | ﹤0.01% | 929 |
|
|
2020
Q3 | $5K | Sell |
52
-40
| -43% | -$4.08K | ﹤0.01% | 943 |
|
|
2020
Q2 | $9K | Sell |
92
-285
| -76% | -$26.5K | ﹤0.01% | 856 |
|
|
2020
Q1 | $31K | Sell |
377
-453
| -55% | -$44.2K | ﹤0.01% | 695 |
|
|
2019
Q4 | $92K | Buy |
830
+38
| +5% | +$3.91K | ﹤0.01% | 587 |
|
|
2019
Q3 | $79K | Buy |
792
+135
| +21% | +$13.4K | ﹤0.01% | 583 |
|
|
2019
Q2 | $64K | Sell |
657
-185
| -22% | -$17.7K | ﹤0.01% | 613 |
|
|
2019
Q1 | $93K | Buy |
842
+185
| +28% | +$19.3K | 0.01% | 547 |
|
|
2018
Q4 | $60K | Sell |
657
-145
| -18% | -$14.7K | ﹤0.01% | 603 |
|
|
2018
Q3 | $88K | Hold |
802
| – | – | 0.01% | 592 |
|
|
2018
Q2 | $75K | Buy |
802
+145
| +22% | +$12.5K | ﹤0.01% | 598 |
|
|
2018
Q1 | $55K | Buy |
657
+605
| +1,163% | +$53.8K | ﹤0.01% | 672 |
|
|
2017
Q4 | $5K | Hold |
52
| – | – | ﹤0.01% | 1102 |
|
|
2017
Q3 | $4K | Buy |
+52
| New | +$3.93K | ﹤0.01% | 1101 |
|
Other funds holding PRAH
Central Trust Company's PRAH Position: Q3 2021 in Review
Central Trust Company sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 52 shares — an estimated $9K sold.
Central Trust Company first reported a position in PRAH in Q3 2017 and held it in 16 quarters. The position peaked at $93K in Q1 2019. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Central Trust Company reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Central Trust Company sold 52 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $9K.
- Central Trust Company first reported a position in PRA Health Sciences, Inc. in Q3 2017 and held it in 16 quarters.
- Central Trust Company's PRA Health Sciences, Inc. position peaked at $93K in Q1 2019.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Central Trust Company's 13F filing for Q3 2021, filed 19 Oct 2021.